Core Insights - The Chinese cosmetics market is undergoing a significant paradigm shift, moving from "scale expansion" to "quality leadership" as it surpasses a market size of 1 trillion yuan and domestic brands exceed international ones in sales [1] - HBN, a skincare brand that has filed for an IPO in Hong Kong, exemplifies this shift by focusing on "slow research-driven efficacy," providing a model for domestic brands aiming for high-end market penetration [1] Group 1: Market Trends - The transition of domestic cosmetics brands to high-end positioning is a notable trend, involving upgrades in brand positioning, product efficacy, and consumer perception [4] - HBN has capitalized on the rise of ingredient-focused consumers and the popularization of scientific skincare, playing a dual role in market education and category definition [4] Group 2: HBN's Product Development - HBN has pioneered the "early C, late A" skincare formula, launching successful products like the dual retinol night cream and brightening water, establishing itself in the high-end retinol market [5] - The brand's retinol skincare products and α-arbutin essence have ranked first in national sales for three consecutive years from 2022 to 2024, with cumulative sales of over 30 million units by the end of 2025 [5] Group 3: Consumer Engagement - HBN has accumulated over 4.6 million high-repeat purchase users, with average transaction values gradually increasing; its repurchase rates on platforms like Tmall and Douyin are approximately 35.4% and 44.0%, respectively [7] Group 4: Research and Development - HBN's commitment to "slow research" has built a systematic innovation capability, driving the brand towards high-end positioning [8] - The company has established a complete research loop from basic research to raw material innovation and efficacy verification, with a research team of 103 professionals across various fields [8][10] - HBN has published over 50 international SCI papers, ranking first among domestic skincare brands in terms of publications as the first author [8] Group 5: Efficacy Verification and Industry Contribution - HBN has developed a comprehensive "full-link multi-dimensional cross-validation system" for product efficacy, being the only Chinese skincare brand to conduct efficacy testing through international authoritative institutions [10] - The brand is also advocating for the establishment of a scientific evaluation system for cosmetic efficacy evidence, marking its transition from a market participant to a contributor to high-quality industry development [10] - This shift signifies HBN's role in defining industry standards and its commitment to high-end brand development through continuous investment in research and innovation [10]

Core Viewpoint - HBN has established itself as a leading domestic skincare brand in China, particularly known for its effective retinol products and the "early C, late A" skincare philosophy, and is now seeking to go public on the Hong Kong Stock Exchange [1][3]. Group 1: Brand Development and Market Position - HBN was founded in 2019 and chose to focus on the challenging retinol market, which was dominated by international brands, by emphasizing ingredient transparency and authoritative evidence [3][4]. - The brand has successfully positioned itself in the market by introducing a comprehensive product line that includes retinol-based skincare products, achieving the highest sales in its category from 2022 to 2024 [4][6]. Group 2: Research and Development Strategy - HBN has invested heavily in R&D and established a comprehensive verification system to ensure that all product claims are backed by clinical data, making it the only Chinese skincare brand to conduct efficacy testing through international authorities [6][7]. - The company has developed a sustainable innovation system that allows for the efficient reuse of research outcomes, leading to the continuous launch of new products and categories [7][9]. Group 3: Financial Performance and User Engagement - As of September 2025, HBN has accumulated over 4.6 million repeat customers, with average repurchase rates of approximately 35.4% on Tmall and 44.0% on Douyin, significantly higher than industry averages [10]. - Financially, HBN reported total revenue of 2.083 billion yuan in 2024, with net profit rising to 129 million yuan, and a 190.3% year-on-year increase in net profit for the first three quarters of 2025 [10].

Core Viewpoint - The Chinese skincare brand HBN, under Shenzhen Hujia Technology (Group) Co., Ltd., has submitted its IPO application to the Hong Kong Stock Exchange, highlighting a growth model driven by deep research and rigorous validation, transitioning from "ingredient claims" to "evidence-based support" [1] Group 1: Research-Driven Innovation - HBN was founded in 2019 with the brand philosophy of "making true efficacy a reality," adhering to a long-term development path of "slow research" [4] - As of September 30, 2025, HBN's R&D team will consist of 103 members with diverse backgrounds in dermatology, medicine, cell biology, and synthetic biology, showcasing interdisciplinary collaboration [5] - HBN ranks third among domestic brands in the number of new cosmetic ingredients registered as of September 2025, indicating innovation extending from product formulation to the source ingredient [7] Group 2: Market Position and Product Innovation - HBN has become the youngest brand among the top ten domestic skincare brands in China, leading the market in the segment of improvement skincare products [7] - HBN's A-alcohol skincare products and α-arbutin essence have ranked first in sales within their category for three consecutive years (2022-2024), establishing a clear category advantage [7] Group 3: Building User Trust and Business Health - HBN has developed a comprehensive "full-link multi-dimensional verification system," recognized as the only skincare brand in China to conduct efficacy testing on all products through international authoritative testing agencies [8] - As of September 2025, HBN has accumulated over 4.6 million repeat customers, with average repurchase rates of approximately 35.4% on Tmall and 44.0% on Douyin, significantly higher than industry averages [9] - In 2024, HBN achieved total revenue of 2.083 billion yuan and a net profit of 129 million yuan, with a net profit margin increasing from 3.5% to 9.6% in the first three quarters of 2025 [9] Group 4: Strategic Significance of IPO - HBN's IPO in Hong Kong marks a critical milestone in its development model of "research-driven innovation and evidence-based trust building," providing a reference for domestic brands to achieve sustainable growth in a competitive market [11]

Core Viewpoint - The Chinese skincare brand HBN, under Shenzhen Hujia Technology (Group) Co., Ltd., has submitted its IPO application to the Hong Kong Stock Exchange, highlighting a growth model driven by deep research and rigorous validation, transitioning from "ingredient claims" to "evidence-based support" in the industry [1] Group 1: Research-Driven Innovation - HBN was founded in 2019 with the brand philosophy of "making true efficacy a reality," adhering to a long-term development path of "slow research" [4] - As of September 30, 2025, HBN's R&D team will consist of 103 members with diverse backgrounds in dermatology, medicine, cell biology, and synthetic biology, showcasing interdisciplinary collaboration [5] - HBN ranks third among domestic brands in the number of new cosmetic ingredients registered as of September 2025, indicating innovation extending from product formulation to the source ingredient [7] Group 2: Market Position and Product Innovation - HBN has become the youngest brand among the top ten domestic skincare brands in China by retail sales in 2024, and it ranks first in the market for improvement-oriented skincare products [7] - HBN's A-retinol skincare products and α-arbutin essence have ranked first in sales within their category for three consecutive years (2022-2024), establishing a clear category advantage [7] - The company has developed a complete product line based on the scientific skincare concept of "Morning C, Evening A," expanding into subcategories like eye creams and neck creams [7] Group 3: Building User Trust and Financial Performance - HBN has established a comprehensive "full-link multi-dimensional verification system," recognized as the only skincare brand in China conducting efficacy testing through international authoritative institutions [8] - As of September 2025, HBN has accumulated over 4.6 million repeat customers, with average repurchase rates of approximately 35.4% on Tmall and 44.0% on Douyin, significantly higher than industry averages [8] - In 2024, HBN achieved total revenue of 2.083 billion yuan and a net profit of 129 million yuan, with a net profit margin increasing from 3.5% to 9.6% in the first three quarters of 2025, indicating a healthy growth model driven by product strength and trust [9] Group 4: Strategic Significance of IPO - HBN's IPO in Hong Kong marks a critical milestone in its development of a "research-driven innovation and evidence-based trust" model, providing a reference for domestic brands on achieving sustainable growth amid intense market competition [11]

Core Viewpoint - The news indicates that Shenzhen Hujia Technology (Group) Co., Ltd., the parent company of the emerging domestic beauty brand HBN, is preparing for an IPO, which has attracted significant attention in the investment and cosmetics industries. The company has completed its shareholding reform, but there is no clear IPO plan yet [1][4]. Company Overview - HBN was founded by Yao Zhenan, who has a background in art design and experience in market operations and user insights. The brand focuses on the high-tech field of retinol anti-aging skincare [5][10]. - HBN's product lines include anti-aging, brightening, and other skincare categories, with a total sales exceeding 7 billion yuan by April 2025. The brand has gained significant traction on platforms like Tmall and Douyin [10][11]. Market Position and Strategy - HBN has established itself as a representative of domestic retinol skincare, leveraging scientific communication strategies to build a professional image and capture consumer attention [7][10]. - The brand has expanded its product offerings beyond retinol to include sunscreen and other effective skincare products, demonstrating a proactive approach to market demands [11][13]. IPO Preparation and Industry Trends - The company's shareholding reform is seen as a preparatory step for an IPO, aimed at optimizing its equity structure and governance system, which could enhance its attractiveness to potential investors [13][14]. - The trend of domestic beauty brands pursuing shareholding reforms or IPOs reflects a shift from rapid growth to more refined operations within the industry, indicating a response to regulatory requirements and the need for capital in a tightening financing environment [14].

Core Viewpoint - HBN has rapidly expanded its "true efficacy" skincare brand, establishing itself as a leading player in the Chinese beauty market, particularly in the anti-aging segment with its flagship product, "Double A Retinol Night Cream" [2][20]. Market Position and Performance - By the first half of 2025, HBN ranked in the top 4 of Tmall's domestic beauty skincare stores and top 5 on Douyin, being the only brand to secure a top 5 position in both platforms [2]. - HBN's "Early C Late A" lotion has sold over 30 million bottles, achieving the number one sales position in the "retinol skincare" and "essence water" categories in China [2]. Research and Development - HBN has published three high-impact SCI papers on α-arbutin, marking a significant contribution to the understanding of its mechanisms in photodamage repair [5][9]. - The research has revealed α-arbutin's potential beyond traditional whitening, demonstrating its anti-inflammatory properties and ability to repair UV-induced skin damage [8][9]. Innovation and Collaboration - HBN has established a comprehensive research framework, including collaborations with top universities and institutions, to explore cutting-edge scientific topics [21]. - The brand has developed four original efficacy raw materials and expanded its research center to over 5,000 square meters, housing over a hundred researchers [20][21]. Consumer Insights and Cultural Relevance - HBN emphasizes a deep understanding of Asian skin types and aesthetics, creating products tailored to local needs, which contrasts with the traditional Western-centric approach [12]. - The collaboration with Pantone to create the "HBN Original White Card" reflects HBN's commitment to culturally relevant skincare solutions [13][15]. Commitment to Safety and Efficacy - HBN has conducted extensive safety studies on its sunscreen products, confirming that their formulations have significantly lower residual levels in human blood than the safety thresholds set by the FDA [16]. - The brand has completed over 4,000 third-party efficacy tests across its entire product line, reinforcing its commitment to "true efficacy" [18][23]. Future Outlook - As consumer demand for effective and safe skincare solutions grows, HBN is positioned to lead the market with its focus on scientific research and genuine product efficacy [24].